Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ReShape Lifesciences, Inc. - Common Stock (NQ:RSLS)

0.3097 -0.0534 (-14.71%)
Streaming Delayed Price Updated: 4:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ReShape Lifesciences, Inc. - Common Stock

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Adial Pharmaceuticals (NASDAQ:ADIL 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Anavex Life Sciences (NASDAQ:AVXL) shares moved upwards by 17.07% to $25.92 during Monday's regular session. Anavex Life Sciences's stock is trading at a... 
Via Benzinga
ReShape Lifesciences Closes First Day of Trading on the NASDAQ Capital Market
Shares of ReShape Lifesciences commenced trading on The Nasdaq Capital Market at market open on June 16, 2021 under the ticker symbol "RSLS" SAN CLEMENTE, CA / ACCESSWIRE / June 17, 2021 / ReShape... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
48 Biggest Movers From Yesterday
Gainers Gaucho Group Holdings, Inc. (NASDAQ: VINO) shares jumped 95.1% to close at $7.98 on Wednesday. Gaucho Group highlighted the launch of its Amazon Storefront. Orphazyme A/S... 
Via Benzinga
ReShape Lifesciences Completes Merger with Obalon Therapeutics
Shares of ReShape Lifesciences to commence trading on The Nasdaq Capital Market on June 16, 2021 under ticker symbol "RSLS" Combination creates opportunity for ReShape to expand portfolio of FDA... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Product Safety Regulatory
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Announce Anticipated Closing of Merger
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 15, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today the anticipated closing of their... 
From ReShape Lifesciences Inc.
Via AccessWire
ReShape Lifesciences Inc. and Obalon Therapeutics, Inc. Update on Status of Pending Merger
SAN CLEMENTE, CA and SAN DIEGO, CA / ACCESSWIRE / June 8, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS) and Obalon Therapeutics, Inc. (NASDAQ:OBLN) announced today that the parties anticipate the... 
From ReShape Lifesciences Inc.
Via AccessWire
Reminder: Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Obalon Therapeutics Continues to Urge Stockholders to Vote FOR All Proposals Related to Merger with ReShape Lifesciences
SAN DIEGO, CA / ACCESSWIRE / May 21, 2021 / Obalon Therapeutics, Inc. (NASDAQ:OBLN), a vertically integrated medical technology company with the first and only FDA-approved swallowable gas-filled... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
Obalon Therapeutics Stockholders Special Meeting Adjourned to May 25, 2021
Urging all Shareholders to Vote For Proposals Related to Merger with ReShape LifeSciences Inc. Meeting to be held via Webcast at 8:30 a.m. Pacific SAN DIEGO, CA / ACCESSWIRE / May 18, 2021 / Obalon... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Regulatory Compliance
Exposures Legal Regulatory
ReShape Lifesciences Announces First Quarter 2021 Financial and Operational Results
SAN CLEMENTE, CA / ACCESSWIRE / May 17, 2021 / ReShape Lifesciences Inc. (OTCQB:RSLS), a leading developer and distributor of minimally invasive medical devices to treat obesity and metabolic diseases,... 
From ReShape Lifesciences Inc.
Via AccessWire
Topics Fraud Intellectual Property
Exposures COVID-19 Intellectual Property Legal
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.